Theravance Biopharma has garnered renewed attention from analysts as the consensus price target for its stock has moved upward from $20.00 to $21.50. This reflects a fresh assessment of the company's ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

At the age of 79, British writer of Ukrainian descent, Marina Lewycka, passed away. She was best known for her debut novel, A ...

Detailed price information for Alterity Therapeutics Limited (PRNAF) from The Globe and Mail including charting and trades.

In the study, authors investigated the natural history of GA lesion incidence rates and analyzed potential risk factors for faster incidence of GA lesions.

As of November 12, 2025, ProMIS has fully enrolled Cohorts 1 and 2 and is well into Cohort 3, with complete enrollment expected before the end of the year. PMN310 continues to demonstrate a favorable ...

The software industry is undergoing a profound transformation, driven by advances in AI. Alexey Astakhov, Vice President of ...

Marina Lewycka’s death at 79 closes a remarkable literary journey shaped by humour, heritage and fierce social insight, leaving a powerful legacy behind., Books, Times Now ...

Rincon isn’t the only beauty buff turning to facial rejuvenation acupuncture, a natural alternative that promises younger, ...

BOSTON, Nov. 13, 2025) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human ...

Under the expanded program, patients across Balochistan will now receive free-of-charge treatment for several high-cost and ...

We at CurePSP extend our heartfelt support to Rev. Jesse L. Jackson, Sr., his family and the entire community of individuals who have been touched by his lifelong pursuit of justice and equity. News ...